Pharma Applauds U.K. Election Outcome But EU Renegotiation Creates Uncertainty
This article was originally published in The Pink Sheet Daily
Executive Summary
Government support for the Cancer Drugs Fund and life sciences will continue, but a referendum vote to leave the EU over the next two years would create a need for new pharma regulations and a move from London of the European Medicines Agency.